A 12-year-old girl from Bangalore presents with recurrent episodes of severe eye pain, photophobia, and blurred vision in the left eye over 2 months. On slit-lamp examination, she has a shield-shaped corneal ulcer with raised edges and stromal infiltration. Conjunctival examination reveals bilateral giant papillae on the upper tarsal surface and a gelatinous limbal swelling. What is the most likely diagnosis and the immediate next step in management?

Explanation

## Diagnosis: Vernal Keratoconjunctivitis (VKC) with Shield Ulcer ### Clinical Presentation **Key Point:** Shield ulcer is a serious complication of VKC that represents focal corneal epithelial loss with stromal infiltration, typically located in the upper third of the cornea. ### Diagnostic Features in This Case | Feature | Finding | Significance | |---------|---------|---------------| | **Age & sex** | 12-year-old girl | Peak VKC age group | | **Seasonality** | Recurrent episodes | Suggests allergic/seasonal pattern | | **Bilateral giant papillae** | Upper tarsal conjunctiva | Pathognomonic for VKC | | **Gelatinous limbal swelling** | Limbal thickening | Characteristic VKC finding (Horner–Trantas dots) | | **Shield ulcer** | Upper third, raised edges, stromal infiltration | Complication of VKC, NOT infectious | | **Symptoms** | Pain, photophobia, blurred vision | Indicates corneal involvement | **Clinical Pearl:** The shield ulcer in VKC is sterile and results from: 1. Chronic mechanical irritation from giant papillae 2. Toxic effects of inflammatory mediators (histamine, leukotrienes, cytokines) 3. Epithelial breakdown and stromal inflammation 4. NOT bacterial infection (culture is negative) ### Management of VKC with Shield Ulcer ```mermaid flowchart TD A[VKC with Shield Ulcer]:::outcome --> B{Corneal involvement?}:::decision B -->|Yes| C[Potent topical corticosteroids]:::action C --> D[Cycloplegics for comfort]:::action D --> E[Mast cell stabilizers]:::action E --> F[Lubricants & cold compresses]:::action F --> G[Monitor for resolution]:::action G --> H{Ulcer healing?}:::decision H -->|Yes| I[Taper steroids slowly]:::action H -->|No| J[Consider immunosuppressants]:::urgent ``` **High-Yield:** Potent topical corticosteroids (prednisolone acetate 1% or dexamethasone 0.1%) are now indicated because: - Corneal involvement is present (shield ulcer) - Steroids suppress inflammatory mediators and promote epithelial healing - The benefit of preventing corneal scarring outweighs the risk of steroid complications in this acute setting - Frequent monitoring (daily) allows early detection of complications **Mnemonic:** **SHIELD ulcer management = Steroids, Healing, Immunosuppression if needed, Epithelial care, Lubricants, Diligent follow-up** ### Why Antibiotics Are NOT First-Line **Warning:** The shield ulcer in VKC is **sterile** — culture and sensitivity will be negative. Antibiotics are: - Unnecessary and ineffective - Potentially toxic to the cornea - A distraction from the real pathology (allergic inflammation) Antibiotics are used only if there is clinical or microbiological evidence of bacterial superinfection (purulent discharge, positive culture). ### Adjunctive Measures - **Cycloplegics** (atropine 1% or homatropine 2%): Reduce ciliary spasm, provide pain relief, and prevent posterior synechiae - **Lubricants**: Protect the cornea and promote healing - **Cold compresses**: Reduce itching and inflammation - **Mast cell stabilizers**: Continue for long-term control ### Monitoring & Prognosis **Clinical Pearl:** Most shield ulcers heal within 1–2 weeks with aggressive topical steroid therapy. Steroids should be tapered slowly over 4–6 weeks to prevent rebound inflammation and recurrence. If the ulcer does not heal or progresses despite therapy, consider: - Systemic immunosuppressants (cyclosporine, tacrolimus) - Surgical intervention (conjunctival flap, amniotic membrane transplantation) in severe cases [cite:Khurana Comprehensive Ophthalmology Ch 4; Parson's Diseases of the Eye 22e Ch 5]